REVA Medical Inc (REVA) is a medical device company that offers bioresorbable polymer technologies for vascular applications. The company offers solutions for patient health restoration through the application of biomaterials in the development and sale of implantable medical devices. It offers fantom, a bioresorbable vascular scaffold developed as an alternative to metallic stents for the treatment of coronary artery disease. It also develops proprietary polymers for scaffold performance. The company's fantom supports the artery through the healing process providing restoration of blood flow. It operates in Australia, Brazil and New Zealand, among others. REVA is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company REVA Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- REVA Medical Inc Company Overview
- REVA Medical Inc Company Snapshot
- REVA Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- REVA Medical Inc - Pipeline Analysis Overview
- REVA Medical Inc - Key Facts
- REVA Medical Inc - Major Products and Services
- REVA Medical Inc Pipeline Products by Development Stage
- REVA Medical Inc Ongoing Clinical Trials by Trial Status
- REVA Medical Inc Pipeline Products Overview
- Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold
- Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold Product Overview
- Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold Clinical Trial
- MOTIV Bioresorbable Scaffold
- MOTIV Bioresorbable Scaffold Product Overview
- MOTIV Bioresorbable Scaffold Clinical Trial
- ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold
- ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold Product Overview
- ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold
- ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold Product Overview
- TYROSPHERE EMBOLIC BEAD
- TYROSPHERE EMBOLIC BEAD Product Overview
- REVA Medical Inc - Key Competitors
- REVA Medical Inc - Key Employees
- REVA Medical Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- REVA Medical Inc, Recent Developments
- Aug 05, 2019: REVA receives additional interim funding
- Mar 24, 2019: REVA receives interim funding commitment and announces leadership changes
- Feb 05, 2019: REVA announces reduction in force
- Jan 07, 2019: Reva expands geographic footprint to seven new countries
- Jan 04, 2019: REVA Medical announces that Leigh Elkolli promoted to chief financial officer
- Jan 03, 2019: Leigh Elkolli promoted to chief financial officer at Reva Medical
- Dec 04, 2018: REVA announces first implant of the Fantom Encore Bioresorbable Scaffold in Italy
- Nov 08, 2018: Reva Medical announces departure of Richard Kimes, SVP of operations
- Nov 06, 2018: Reva Medical reports third quarter 2018 financial results
- Oct 31, 2018: REVA announces commercial launch of the Fantom Encore Bioresorbable Scaffold
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- REVA Medical Inc Pipeline Products and Ongoing Clinical Trials Overview
- REVA Medical Inc Pipeline Products by Equipment Type
- REVA Medical Inc Pipeline Products by Indication
- REVA Medical Inc Ongoing Clinical Trials by Trial Status
- REVA Medical Inc, Key Facts
- REVA Medical Inc, Major Products and Services
- REVA Medical Inc Number of Pipeline Products by Development Stage
- REVA Medical Inc Pipeline Products Summary by Development Stage
- REVA Medical Inc Ongoing Clinical Trials by Trial Status
- REVA Medical Inc Ongoing Clinical Trials Summary
- Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status
- Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description
- Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Expanded FANTOM II Clinical Study
- Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Pilot Study of the REVA Sirolimus-Eluting Bioresorbable Coronary Scaffold
- Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Post Market Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold
- Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Safety and Efficacy of the FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo Coronary Artery Disease: The ENCORE-I Study
- Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Safety and Performance Study of the FANTOM Sirolimus-eluting Bioresorbable Coronary Scaffold
- Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold - Vascular Healing Pattern, Vasoreactivity, and Quality of Life in Patients with ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention with Sirolimus Eluting FANTOM Bioresorbable Vascular Scaffold with Long Term Clinical, Near Infrared Spectroscopy and Optical Coherence Tomography Follow-up: A FANTOM STEMI Pilot Study
- MOTIV Bioresorbable Scaffold - Product Status
- MOTIV Bioresorbable Scaffold - Product Description
- MOTIV Bioresorbable Scaffold - A Prospective, Multicenter, Single Blind, Randomized Controlled Trial Evaluating the Safety and Effectiveness of the MOTIV Sirolimus-Eluting Bioresorbable Vascular Scaffold Compared With Plain Balloon Angioplasty for the Treatment of Infrapopliteal Lesions
- MOTIV Bioresorbable Scaffold - Physician-initiated Trial Investigating the MOTIV Bioresorbable Scaffold (Reva Medical) for the Treatment of Below-the-knee Artery Disease
- ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Status
- ReZolve Sirolimus-Eluting Bioresorbable Coronary Scaffold - Product Description
- ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Status
- ReZolve2 Drug Eluting Bioresorbable Coronary Scaffold - Product Description
- TYROSPHERE EMBOLIC BEAD - Product Status
- TYROSPHERE EMBOLIC BEAD - Product Description
- REVA Medical Inc, Key Employees
- REVA Medical Inc, Subsidiaries
- Glossary
- REVA Medical Inc Pipeline Products by Equipment Type
- REVA Medical Inc Pipeline Products by Development Stage
- REVA Medical Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Endologix LLC
- Hypertension Diagnostics, Inc
